Literature DB >> 15894458

A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis.

David C Mohr1, Daniel Pelletier.   

Abstract

A growing literature reports that stressful life events are associated with exacerbation and the subsequent development of brain lesions in patients with multiple sclerosis (MS). The evolution an MS exacerbation occurs over a period of many months and involves many different biological processes that change over time. Likewise, the experience of stress also occurs over time, with an onset, a shift from acute to chronic in some cases, and resolution. Each of these phases is associated with unique biological features. Thus, the impact of stress on MS exacerbation may depend on the temporal trajectories of stress and MS exacerbation, and when the intersection between these two trajectories occurs. This paper presents a temporal model, along with three different temporal relationships and associated mechanisms by which stress may impact MS exacerbation. These include the onset of a stressor, which may be mediated by mast cell activation, the point that a stressor begins to become chronic, which may be mediated by glucocorticoid resistance in immune cells, and the resolution of the stressor, which may be mediated by a drop in cortisol. These three hypotheses are not necessarily mutually exclusive. Data on psychosocial mediators and moderators are also briefly reviewed and future research directions are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15894458     DOI: 10.1016/j.bbi.2005.03.011

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  21 in total

1.  Interleukin-6 as a mechanism for the adverse effects of social stress on acute Theiler's virus infection.

Authors:  Mary W Meagher; Robin R Johnson; Erin E Young; Elisabeth G Vichaya; Shannon Lunt; Elizabeth A Hardin; Marilyn A Connor; C Jane R Welsh
Journal:  Brain Behav Immun       Date:  2007-06-25       Impact factor: 7.217

Review 2.  Stress and multiple sclerosis.

Authors:  David C Mohr
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

Review 3.  Prospects for epigenetic epidemiology.

Authors:  Debra L Foley; Jeffrey M Craig; Ruth Morley; Craig A Olsson; Craig J Olsson; Terence Dwyer; Katherine Smith; Richard Saffery
Journal:  Am J Epidemiol       Date:  2009-01-12       Impact factor: 4.897

4.  Stress and the risk of multiple sclerosis.

Authors:  T Riise; D C Mohr; K L Munger; J W Rich-Edwards; I Kawachi; A Ascherio
Journal:  Neurology       Date:  2011-05-31       Impact factor: 9.910

Review 5.  [Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice].

Authors:  Hans-Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2014-05-20

6.  Development of the brief inventory of perceived stress.

Authors:  Kenneth A Lehman; Michelle Nicole Burns; Emily C Gagen; David C Mohr
Journal:  J Clin Psychol       Date:  2012-03-30

7.  A randomized trial of stress management for the prevention of new brain lesions in MS.

Authors:  David C Mohr; Jesus Lovera; Ted Brown; Bruce Cohen; Thomas Neylan; Roland Henry; Juned Siddique; Ling Jin; David Daikh; Daniel Pelletier
Journal:  Neurology       Date:  2012-07-11       Impact factor: 9.910

Review 8.  Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms.

Authors:  Gregory E Miller; Edith Chen; Karen J Parker
Journal:  Psychol Bull       Date:  2011-11       Impact factor: 17.737

9.  Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis?

Authors:  M N Burns; E Nawacki; M J Kwasny; D Pelletier; D C Mohr
Journal:  Psychol Med       Date:  2013-05-17       Impact factor: 7.723

10.  Prospective examination of anxiety and depression before and during confirmed and pseudoexacerbations in patients with multiple sclerosis.

Authors:  Michelle Nicole Burns; Ewa Nawacki; Juned Siddique; Daniel Pelletier; David C Mohr
Journal:  Psychosom Med       Date:  2012-11-28       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.